| Value | ₹10.00 Cr |
|---|---|
| Execution period | by end of Q2 FY27 |
BSE filing, NSE: ROSSARI. Summary written from the filing by ALFA Finder's alert engine.
Rossari Biotech Ltd: key numbers
- Share price
- ₹407.35
- Market cap
- ₹2,256 Cr
- Revenue (annual)
- ₹2,396 Cr
- Net profit (annual)
- ₹149.2 Cr
- P/E (TTM)
- 14.8×Sector 33.6×
- Promoter holding
- 68.14%+0.00% QoQ
- FII holding
- 1.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rossari Biotech Ltd
All →Rossari Biotech Earnings Call Transcript: Key Takeaways
Rossari Biotech achieved record quarterly revenue and EBITDA despite volatile raw material costs and logistical headwinds.
- Call
- Guides 15% growth
Rossari Biotech Results Update
Rossari Biotech reported Q2 FY27 revenue of Rs. 697.6 crore, up 19% YoY. The company also announced plans for a new manufacturing facility in Saudi Arabia.
Rossari Biotech Investor Presentation: Key Takeaways
Rossari Biotech reported record quarterly revenue of Rs. 697.6 Cr (up 19% YoY) and EBITDA of Rs. 87 Cr (up 21% YoY). Performance driven by volume and product mix.
Rossari Biotech Q2 FY27 Results: Net Profit ₹38.9 Cr, Up 5.4% YoY
Rossari Biotech Ltd reported revenue from operations of ₹697.6 Cr (+19.0% YoY) and net profit of ₹38.9 Cr (+5.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹38.9 Cr · +5.4% YoY
Rossari Biotech Other Announcement
Rossari Biotech submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes minor reporting adjustments for two promoter group members.
Rossari Biotech Board Meeting Date
Rossari Biotech will hold a board meeting on October 17, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.
Other merger & restructuring announcements
All →Godawari Power & Ispat Merger & Restructuring Worth ₹10.95 Cr
GPIL sold 3,67,200 Jammu Pigments shares for Rs 10.95 Crore, cutting its stake from 38.27% to 36.38%. This third tranche is part of a wider associate divestment.
- Value
- ₹10.95 Cr
Hinduja Global Solutions Merger & Restructuring
Hinduja Global Solutions updated on its subsidiary IMCL's plan to sell its entire stake in Bhima Riddhi and Vinsat to external buyers. Completion is taking longer, and both will cease to be step-down subsidiaries on completion.
Ganesh Benzoplast Merger & Restructuring Worth ₹1,066 Cr
Ganesh Benzoplast seeks shareholder approval via postal ballot for a Rs 1,066 Crore slump sale of its liquid storage terminal business to Cisternina Logistics, and a rail logistics business transfer. E-voting runs 6 November to 5 December 2026.
- Value
- ₹1,066 Cr
Ceigall India Merger & Restructuring Worth ₹86.32 Cr
Ceigall India Ltd will infuse Rs. 86.32 Crore into its step-down subsidiary, Ceigall Ambala Chandigarh Zirakpur Limited. The investment supports a 6-lane spur connectivity highway project in Punjab.
- Value
- ₹86.32 Cr
- highway length
- 10.3 Km
Computer Age Management Services Merger & Restructuring
CAMS disclosed the voluntary liquidation and dissolution of its non-material step-down subsidiary Think Analytics under IBC Section 59. The closure has no impact on company operations.
India Glycols Merger & Restructuring
India Glycols disclosed that IGL Spirits received BSE and NSE listing approval for 6.70 crore demerger shares. Trading in these equity shares begins on 4 November 2026.